Georg and her colleagues also presented their findings during the American Chemical Society’s (ACS) 251st annual meeting and exposition.
More than 100 media outlets, including Mic.com (New York, NY: 11.4 million unique monthly visits), Newsweek (U.S.: 4.8 million unique monthly visits), Daily Express (London, U.K.: 4.0 million unique monthly visits), Tech Times (New York, NY: 15.6 million unique monthly visits), RedOrbit (Dallas, TX: 7.6 million unique monthly visits), Vice (U.S.: 7.3 million unique monthly visits), News Medical (Sydney, Australia: 6.5 million unique monthly visits), The Sun (London, U.K.: 2.9 million unique monthly visits), El Mercurio (Santiago, Chile: 2.4 million unique monthly visits), The Times (London, U.K.: 465,900 unique monthly visits), The Australian (296,300 unique monthly visits), ABP Live (Mumbai, India: 228,600 unique monthly visits), Joe.ie (Dublin, Ireland: 111,800 unique monthly visits), Joe.co.uk (U.K.: 66,100 unique monthly visits), Jewish Business News (Tel Aviv, Israel: 46,900 unique monthly visits), and The Hans India (Hyderabad, India: 35,200 unique monthly visits) covered the story.
Gunda Georg is featured in the University of Minnesota Foundation story, "Curtain up: A new drug for pancreatic cancer takes the stage for clinical trials, thanks to the Masonic Cancer Center experts who developed it." Dr. Georg is also featured in the Bath Chronicle story, "A birth control pill for men is on its way and it's going to change everything."
Gunda Georg is featured in the Care2 story, "Coming Soon: More Birth Control Options for Men."
More than 100 media outlets, including Mic.com (New York, NY: 11.4 million unique monthly visits), Newsweek (U.S.: 4.8 million unique monthly visits), Daily Express (London, U.K.: 4.0 million unique monthly visits), Tech Times (New York, NY: 15.6 million unique monthly visits), RedOrbit (Dallas, TX: 7.6 million unique monthly visits), Vice (U.S.: 7.3 million unique monthly visits), News Medical (Sydney, Australia: 6.5 million unique monthly visits), The Sun (London, U.K.: 2.9 million unique monthly visits), El Mercurio (Santiago, Chile: 2.4 million unique monthly visits), The Times (London, U.K.: 465,900 unique monthly visits), The Australian (296,300 unique monthly visits), ABP Live (Mumbai, India: 228,600 unique monthly visits), Joe.ie (Dublin, Ireland: 111,800 unique monthly visits), Joe.co.uk (U.K.: 66,100 unique monthly visits), Jewish Business News (Tel Aviv, Israel: 46,900 unique monthly visits), and The Hans India (Hyderabad, India: 35,200 unique monthly visits) covered the story.
Gunda Georg is featured in the University of Minnesota Foundation story, "Curtain up: A new drug for pancreatic cancer takes the stage for clinical trials, thanks to the Masonic Cancer Center experts who developed it." Dr. Georg is also featured in the Bath Chronicle story, "A birth control pill for men is on its way and it's going to change everything."
Gunda Georg is featured in the Care2 story, "Coming Soon: More Birth Control Options for Men."